Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Maluquer, C."'
Autor:
Arribas, I.1 (AUTHOR), Maluquer, C.1 (AUTHOR), Pomares, H.1 (AUTHOR), Carro, I.1 (AUTHOR), Baca, C.1 (AUTHOR), Bosch, A.1 (AUTHOR), Arévalo, C. E.1 (AUTHOR), Montané, C.1 (AUTHOR), Ribes-Amorós, J.1 (AUTHOR), Zamora, L.2 (AUTHOR), Granada, I.2 (AUTHOR), Gamundi, E.3 (AUTHOR), Arnan, M.1 (AUTHOR), Sureda, A.1 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Oct2023, Vol. 64 Issue 10, p1701-1705. 5p.
Autor:
Gonzalez-Gil C; Institut d'Investigacio contra la Leucemia Josep Carreras (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Morgades M; Departament d'Hematologia Clinica, ICO-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Lopes T; Institut d'Investigacio contra la Leucemia Josep Carreras (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Fuster-Tormo F; Institut d'Investigacio contra la Leucemia Josep Carreras (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Montesinos P; Hospital Universitari i Politecnic La Fe, Valencia., Barba P; Servei Hematologia Clinica, Hospital Universitari de la Vall d'Hebron, Barcelona., Diaz-Beya M; Servei Hematologia Clinica, Hospital Clinic de Barcelona, Barcelona., Hermosin L; Servicio Hematologia Clinica, Hospital de Jerez, Jerez de la Frontera., Maluquer C; Servei Hematologia Clinica, Hospital Duran i Reynals-ICO, Hospitalet del Llobregat., Gonzalez-Campos J; Servicio Hematologia Clinica, Hospital Virgen del Rocio, Sevilla., Bernal T; Servicio Hematologia Clinica, Hospital Central de Asturias, Instituto de Investigacion Sanitario del Principado de Asturias (ISPA), Instituto Oncologico Universitario del Principado de Asturias (IUOPA), Oviedo., Arriaga MS; Institut Catala d'Oncologia (ICO), Hospital Josep Trueta, Girona., Zamora L; Departament d'Hematologia Clinica, ICO-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Pratcorona M; Servei Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona., Martino R; Servei Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona., Larrayoz MJ; Laboratorio Enfermedades Hematologica, CIMA, Navarra., Artola T; Servicio Hematologia Clinica, Hospital Universitario de Donostia., Torrent A; Departament d'Hematologia Clinica, ICO-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Vall-Llovera F; Servei Hematologia Clinica, Hospital Mutua de Terrassa., Tormo M; Hospital Clinico Universitario, Instituto de investigacion INCLIVA, Valencia., Gil C; Servicio Hematologia Clinica, Hospital General de Alicante., Novo A; Servicio Hematologia Clinica, Hospital Son Espases, Palma de Mallorca., Martinez-Sanchez P; Servicio Hematologia Clinica, Hospital 12 de Octubre, Madrid., Ribera J; Institut d'Investigacio contra la Leucemia Josep Carreras (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Queipo MP; Servicio Hematologia Clinica, Hospital Virgen de la Victoria, Malaga., Gonzalez-Martinez T; Servicio Hematologia Clinica, Hospital Universitario de Salamanca., Cabrero M; Servicio Hematologia Clinica, Hospital Universitario de Salamanca., Cladera A; Servicio Hematologia Clinica, Hospital Son Llatzer, Palma de Mallorca., Cervera J; Hospital Universitari i Politecnic La Fe, Valencia., Orfao A; Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Departamento de Medicina, Universidad de Salamanca, Instituto Biosanitario de Salamanca, CIBERONC, Salamanca., Ribera JM; Institut d'Investigacio contra la Leucemia Josep Carreras (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain; Departament d'Hematologia Clinica, ICO-Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona., Genesca E; Institut d'Investigacio contra la Leucemia Josep Carreras (IJC), Campus ICO-Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona. egenesca@carrerasresearch.org.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Heald JS; Epigenetic Therapies Group, Experimental and Clinical Hematology Program, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., López AM; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Pato ML; Epigenetic Therapies Group, Experimental and Clinical Hematology Program, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Ruiz-Xivillé N; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Cabezón M; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Zamora L; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Vives S; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Coll R; Hematology Department, Catalan Institute of Oncology-Hospital Universitari Dr. Josep Trueta, Girona, Spain., Maluquer C; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, Bellvitge Institute for Biomedical Research, Universitat de Barcelona, Barcelona, Spain., Granada I; Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Solé F; Myelodysplastic Syndromes Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona, Spain., Esteller M; Cancer Epigenetics Group, Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer, Madrid, Spain., Berdasco M; Epigenetic Therapies Group, Experimental and Clinical Hematology Program, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.
Publikováno v:
Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2691-2694.
Autor:
Ribera JM; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain., Morgades M; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain., Ribera J; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain., Montesinos P; Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain., Cano-Ferri I; Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain., Martínez P; Department of Hematology Hospital Doce de Octubre Madrid Spain., Esteve J; Department of Hematology Hospital Clínic Barcelona Spain., Esteban D; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain., García-Fortes M; Department of Hematology Hospital Universitario Virgen de la Victoria Málaga Spain., Alonso N; Department of Hematology Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain., González-Campos J; Department of Hematology Hospital Universitario Virgen del Rocío. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/CIBERONC. Universidad de Sevilla Sevilla Spain., Bermúdez A; Department of Hematology Hospital Universitario Marqués de Valdecilla Santander Spain., Torrent A; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain., Genescà E; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain., Maluquer C; Department of Hematology, ICO-Hospital Duran i Reynals Hospitalet de Llobregat Spain., Martínez-López J; Department of Hematology Hospital Doce de Octubre Madrid Spain., García-Sanz R; Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC) Salamanca Spain.
Publikováno v:
HemaSphere [Hemasphere] 2024 Apr 02; Vol. 8 (4), pp. e67. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Autor:
Castaño-Díez S; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Pomares H; Hematology Department, Institut Català d'Oncologia (ICO), Hospital Duran i Reynals, Hospitalet de Llobregat, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Esteban D; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain., Guijarro F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Section, Servei d'Anatomia Patològica, CDB, Hospital Clínic Barcelona, Barcelona, Spain., Jiménez-Vicente C; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Zugasti I; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain., Álamo JR; Hematopathology Section, Servei d'Anatomia Patològica, CDB, Hospital Clínic Barcelona, Barcelona, Spain., Mayayo VT; Universitat de Barcelona, Barcelona, Spain., López-Guerra M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Section, Servei d'Anatomia Patològica, CDB, Hospital Clínic Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., de la Fuente C; Hematology Department, Institut Català d'Oncologia (ICO), Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain., Charry P; Apheresis Department, Hospital Clínic Barcelona, Barcelona, Spain., Cortés-Bullich A; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain., Bataller Á; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Badalona, Spain., Maluquer C; Hematology Department, Institut Català d'Oncologia (ICO), Hospital Duran i Reynals, Hospitalet de Llobregat, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Colomer D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Section, Servei d'Anatomia Patològica, CDB, Hospital Clínic Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Rozman M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematopathology Section, Servei d'Anatomia Patològica, CDB, Hospital Clínic Barcelona, Barcelona, Spain., Arnan M; Hematology Department, Institut Català d'Oncologia (ICO), Hospital Duran i Reynals, Hospitalet de Llobregat, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Xicoy B; Hematology Department, Institut Català d'Oncologia (ICO), Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Badalona, Spain., Esteve J; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Badalona, Spain., Díaz-Beyá M; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Josep Carreras Leukaemia Research Institute, Badalona, Spain.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 892-897. Date of Electronic Publication: 2023 Nov 27.
Autor:
Pinato, DJ, Aguilar-Company, J, Ferrante, D, Hanbury, G, Bower, M, Salazar, R, Mirallas, O, Sureda, A, Plaja, A, Cucurull, M, Mesia, R, Townsend, S, Jackson, A, Dalla Pria, A, Newsom-Davis, T, Handford, J, Sita-Lumsden, A, Apthorp, E, Vincenzi, B, Bertuzzi, A, Brunet, J, Lambertini, M, Maluquer, C, Pedrazzoli, P, Biello, F, Sinclair, A, Bawany, S, Khalique, S, Rossi, S, Rogers, L, Murphy, C, Belessiotis, K, Carmona-Garcia, MC, Sharkey, R, Garcia-Illescas, D, Rizzo, G, Perachino, M, Saoudi-Gonzalez, N, Doonga, K, Fox, L, Roldan, E, Gaidano, G, Ruiz-Camps, I, Bruna, R, Patriarca, A, Martinez-Vila, C, Cantini, L, Zambelli, A, Giusti, R, Mazzoni, F, Caliman, E, Santoro, A, Grosso, F, Parisi, A, Queirolo, P, Aujayeb, A, Rimassa, L, Prat, A, Tucci, M, Libertini, M, Grisanti, S, Mukherjee, U, Diamantis, N, Fusco, V, Generali, D, Provenzano, S, Gennari, A, Tabernero, J, Cortellini, A
Publikováno v:
LANCET ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19 during the omicron outbreak compared with the prevaccination period and alpha (B.1.1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4a67786bb4e1096fb306c45ffab05396
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7192
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7192
Autor:
Blazevic, D., Pomares, H., Boqué, C., Galiano, M., Villarreal, J., Maluquer, C., Sureda, A., Arnan, M., Antonio, M.
Publikováno v:
In Leukemia Research September 2021 108 Supplement
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cortellini A; Department of Surgery and Cancer, Imperial College London, London, UK; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy. Electronic address: a.cortellini@imperial.ac.uk., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Salazar R; Catalan Institute of Oncology (ICO), University of Barcelona, Bellvitge Biomedical Research Institute (IDIBELL), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain., Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Maluquer C; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Ferrante D; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Mirallas O; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain., Plaja A; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology, Badalona, Spain., Cucurull M; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology, Badalona, Spain., Mesia R; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology, Badalona, Spain., Dalla Pria A; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Apthorp E; Medical School, King's College London, London, UK., Vincenzi B; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy., Di Fazio GR; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy., Tonini G; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy., Pantano F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lambertini M; Medical Oncology Department, UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Pedrazzoli P; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy., D'Avanzo F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy., Lee AJX; Cancer Division, University College London Hospitals, London, UK., Shawe-Taylor M; Cancer Division, University College London Hospitals, London, UK., Rogers L; Cancer Division, University College London Hospitals, London, UK., Murphy C; Cancer Division, University College London Hospitals, London, UK., Cooper L; Cancer Division, University College London Hospitals, London, UK., Andaleeb R; Cancer Division, University College London Hospitals, London, UK., Khalique S; Cancer Division, University College London Hospitals, London, UK., Bawany S; Cancer Division, University College London Hospitals, London, UK., Ahmed S; Cancer Division, University College London Hospitals, London, UK., Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Fort-Culillas R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Perachino M; Medical Oncology Department, UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy., Doonga K; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy., Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy., Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Pérez Criado I; Fundació Althaia Manresa, Manresa, Spain., Giusti R; Medical Oncology, St Andrea Hospital, Rome, Italy., Mazzoni F; Medical Oncology, Careggi University Hospital, Florence, Italy., Antonuzzo L; Medical Oncology, Careggi University Hospital, Florence, Italy., Santoro A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Queirolo P; Melanoma and Sarcoma Medical Treatment Unit, IEO, European Institute of Oncology IRCCS, Milan, Italy., Aujayeb A; Respiratory Department, Northumbria Healthcare NHS Foundation Trust, North Shields, UK., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Bertulli R; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fulgenzi CAM; Department of Surgery and Cancer, Imperial College London, London, UK; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy., D'Alessio A; Department of Surgery and Cancer, Imperial College London, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Ruiz-Camps I; Department of Infectious Diseases, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Saoudi-Gonzalez N; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain., Garcia Illescas D; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain., Medina I; Department of Hematology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Fox L; Department of Hematology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain; Department of Infectious Diseases, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Apr; Vol. 24 (4), pp. 335-346. Date of Electronic Publication: 2023 Mar 07.